Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Aug 2018
At a glance
- Drugs Insulin degludec/insulin aspart (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 03 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 06 Sep 2016 Status changed from not yet recruiting to recruiting.